Cocrystal Pharma Inc reports results for the quarter ended in September - Earnings Summary

Cocrystal Pharma

14/11/2022 14:33

* Cocrystal Pharma Inc  COCP.OQ  reported a quarterly
adjusted
loss of 70 cents​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 48 cents per share.
    * Reported revenue was zero​; analysts expected $83.33
thousand. 
    * Cocrystal Pharma Inc's reported EPS for the quarter was a
loss
of 70 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Cocrystal Pharma Inc shares had fallen by 13.2% this
quarter and
lost 61.2% so far this year.
    * The company reported a quarterly loss of $5.7 million.
    * Wall Street's median 12-month price target for Cocrystal
Pharma
Inc is $42.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.48          -0.70          Missed
 Jun. 30 2022      -0.52          -3.00          Missed
 Mar. 31 2022      -0.42          -0.48          Missed
 Dec. 31 2021      -0.48          -0.48          Met